Enzo Biochem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 20   

Articles published

ENZ 6.08 +0.13 (2.18%)
price chart
News Buzz : Cree (NASDAQ:CREE), Newmont Mining Corporation (NYSE:NEM ...
Enzo Biochem, Inc. (NYSE:ENZ), a week ago announced the leading authority in Women's health Diagnostics, Thomas C. Wright, MD, joined the company as a consulting pathologist.
Active Watch List: TriQuint Semiconductor (NASDAQ:TQNT), LiveDeal ...
On July 29, Enzo Biochem Inc. (NYSE:ENZ) announced that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markman hearing, involving Enzo Life Science's U.S.
Watch List : Walgreen Co. (NYSE:WAG), Hertz Global Holdings (NYSE:HTZ ...
On JULY 29, Enzo Biochem, Inc. (NYSE:ENZ) announced that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markmanhearing, involving Enzo Life Science's U.S.
Related articles »  
Post-AbbVie: Written Description And Functional Claiming
In 2002, the Federal Circuit in Enzo Biochem Inc. v. Gen-Probe Inc.[13] addressed the validity of claims to compounds defined by their functional ability to hybridize to chromosomal DNA according to certain parameters.
Cambrex Corporation (CBM) in Focus: Stock Up 7.3%
Cambrex Corporation. (CBM - Snapshot Report) was a big mover last session, as the company saw its shares rise over 7% on the day.
Pacira Up on Narrower-than-Expected Loss, Revenue Beat in Q2
Pacira Pharmaceuticals, Inc.'s (PCRX - Snapshot Report) shares have been inching up since the company reported a narrower-than-expected loss for the second quarter of 2014.
Related articles »  
Seattle Genetics Up on Narrower-than-Expected Q2 Loss
Seattle Genetics, Inc.'s shares (SGEN - Snapshot Report) gained 4.8% following the release of second-quarter 2014 results.
Why car rental prices keep going up
For real: Shares in Avis Budget Group Inc. are up 69% this year and hit an all-time high of $68.14 on Aug. 15. ... And here is some for the purposes of this column: There's actually a local biotech stock (Enzo Biochem) that's up even more than Avis Budget.
Related articles »  
Affymetrix Down despite Q2 Earnings and Revenues Beat
Currently, Affymetrix carries a Zacks Rank #3 (Hold). Better-ranked stocks in the biomedical/gene industry include Actelion Ltd. (ALIOF), China Biologic Products, Inc. (CBPO) and Enzo Biochem Inc. (ENZ). All these stocks sport a Zacks Rank #1 (Strong Buy).
Affymetrix Down despite Q2 Earnings and Revenues Beat - Analyst Blog  NASDAQ
Related articles »  
Seattle Genetics Up on Narrower-than-Expected Q2 Loss - Analyst Blog
Seattle Genetics, Inc. 's shares ( SGEN ) gained 4.8% following the release of second-quarter 2014 results. Seattle Genetics reported second-quarter loss per share of 14 cents, narrower than the Zacks Consensus Estimate of a loss of 22 cents but wider ...
Related articles »